<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html><head><title>6th Ocular Diseases Drug Discovery</title>
<meta content=en-us http-equiv=Content-Language>
<meta content="text/html; charset=iso-8859-1" http-equiv=Content-Type><base 
target=_blank>
<meta name=GENERATOR content="MSHTML 8.00.6001.18939"></head>
<body>
<table cellSpacing=0 cellPadding=0 width=820 align=center>
  <tbody>
  <tr height=36>
    <td><font style="FONT-SIZE: 9pt" face=Arial>If you can't view this page, 
      please visit: <font color=#367e8d><a 
      href="http://www.gtcbio.com/newsletter/ocu14I-w.htm">http://www.gtcbio.com/newsletter/ocu14I-w.htm</a> 
      </font></font><font style="FONT-SIZE: 8pt" color=#ffffff face=Arial>JMEL-25246 
      <br> </font></td></tr>
  <tr height=36>
    <td><font face=Arial><b><i><font size=2>Agenda is now 
      online!</font></i><br><a 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">6th 
      Ocular Diseases Drug Discovery Conference</a><br></b><font size=2><font 
      color=#666666><b>March 20-21, 2014 | San Diego, CA | </b><a 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">www.gtcbio.com/ocular</a></font></font></font></td></tr>
  <tr>
    <td vAlign=top><font size=2 face=Arial><br>Dear Colleague, <br><br>The 
      preliminary <a 
      href="https://www.gtcbio.com/component/conference/ocular-diseases-and-drug-discovery-agenda?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">agenda</a> 
      for the<a 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I"> 
      <b>6th Annual Ocular Diseases Drug Discovery Conference</b></a> has been 
      posted! Join leading scientists and experts to discuss the latest research 
      and development on therapies for ocular surface diseases, anterior and 
      posterior segment diseases. The conference will feature novel delivery 
      technologies and share strategies for collaborations and 
      investments.<br><br>Network with colleagues to exchange ideas and discuss 
      the challenges of bringing new and innovative treatments to patients in 
      the area of ophthalmology. Below are topics scheduled to be 
      discussed:<br> </font></td></tr>
  <tr>
    <td vAlign=top><u><font size=2 
face=Arial><b>Sessions</b>:</font></u></td></tr>
  <tr>
    <td vAlign=top>
      <ol style="FONT-FAMILY: Arial; FONT-SIZE: 10pt" type=I>
        <li>Novel Targets, Developments and Technologies 
        <li>Novel Drug Delivery Methods to the Anterior and Posterior Segments 
        <li>Clinical Development Advances & Updates 
        <li>Safety Assessment and Regulatory Landscape in Ocular Drug 
        Development </li></ol></td></tr>
  <tr>
    <td vAlign=top><b><u><font size=2 face=Arial>Panel 
      Discussions</font></u></b></td></tr>
  <tr>
    <td vAlign=top>
      <ol style="FONT-FAMILY: Arial; FONT-SIZE: 10pt" type=I>
        <li>Business Development, Investments and Potential for Collaborations 
        <li>Changing Landscape for AMD Drugs 
        <li>Novel Technologies for Patient Adherence & Compliance<br>  
        </li></ol></td></tr>
  <tr>
    <td vAlign=top>
      <p align=left><u><b><font face=Arial>New this 
  year!</font></b></u></p></td></tr>
  <tr>
    <td vAlign=top><font size=2><span style="FONT-FAMILY: Arial"><i>Interested 
      in biomarkers?</i> GTC's annual <b><a 
      href="http://www.gtcbio.com/conference/biomarker-summit-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">Biomarker 
      Summit</a></b> will be co-located with the <b><a 
      style="TEXT-DECORATION: none" 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I"><font 
      color=#000000>Ocular Conference</font></a></b>. GTC has added an 
      additional registration option for individuals interested in both topics! 
      The Biomarker Summit features 3 distinct streams:<br><b><i> - <a 
      href="http://www.gtcbio.com/conference/oncology-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">7th 
      Oncology Biomarkers</a><br> - <a 
      href="http://www.gtcbio.com/conference/neurological-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">3rd 
      Neurological Biomarkers</a><br> - <a 
      href="http://www.gtcbio.com/conference/inflammatory-and-immunological-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">3rd 
      Inflammatory / Immunological 
    Biomarkers</a></i></b><br> </span></font></td></tr>
  <tr>
    <td vAlign=top><font size=2 face=Arial><u><b><font 
      color=#ff3300>REGISTRATION INFORMATION:</font><br></b></u><b><i>Register 
      by January 19, 2014 to take advantage of the 20% 
    discount!</i></b></font></td></tr>
  <tr>
    <td vAlign=top><b><font size=2 face=Arial>1) </font></b><font size=2 
      face=Arial><b><a 
      href="https://www.gtcbio.com/register/ocular-diseases-and-drug-discovery?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">Register</a></b> 
      for the <a style="TEXT-DECORATION: none" 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I"><font 
      color=#000000>Ocular Diseases Drug Discovery Conference</font></a> early 
      <u>and save up to $350</u>.<br><b>2)</b> <b><a 
      href="https://www.gtcbio.com/register/ocular-diseases-and-drug-discovery?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">Register</a></b> 
      for the Biomarker Summit <b>+</b> the Ocular Conference early <u>and save 
      up to $450.</u><br><b>3) </b>Group Discount:<b> <a 
      href="https://www.gtcbio.com/register/ocular-diseases-and-drug-discovery?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">Sign 
      up</a></b> 3 people for the price of 2! Use discount code 
      <b>rcdvb</b>.<br> </font></td></tr>
  <tr><font size=2 face=Arial>
    <td bgColor=#dceefa height=30>
      <p align=center><b><font size=3 face=arial>DISTINGUISHED SPEAKERS & 
      SCIENTIFIC ADVISORY BOARD MEMBERS</font></b></p></td></font></tr>
  <tr>
    <td vAlign=top><font size=2 face=Arial><br>Robert Butchofsky, President 
      and Chief Executive Officer, <b>Mati Therapeutics</b><br><br>Chi-Chao 
      Chan, Immunopathology Section, Laboratory of Immunology and Head, 
      Histopathology Core, <b>National Eye Institute, National Institutes of 
      Health</b><br><br>Patrik De Haes, Chief Executive Officer, 
      <b>Thrombogenics</b><br><br>Amin Famili, <b>University of Colorado 
      Denver</b><br><br>Rafal Farjo, Chief Operating Officer, 
      <b>EyeCRO</b><br><br>Patrick Healy, CEO, <b>Trial 
      Runners</b><br><br>Gregory Jackson, Associate Professor, Opthalmology and 
      Neural & Behavioral Sciences,<b> Penn State College of 
      Medicine</b><br><br>Paul L. Kaufman, Peter A. Duehr Professor & Chair, 
      Ernst H. Barany Professor of Ocular Pharmacology, Department of 
      Ophthalmology & Visual Sciences, School of Medicine & Public 
      Health, <b>University of Wisconsin-Madison</b><br><br>Jennifer Le Couter, 
      Research Scientist, <b>Genentech</b><br><br>Kenneth Mandell, Drug 
      Development Consultant, Entrepreneur, <b>MIT</b> <br><br>Sarah Abdulla 
      Molokhia, Scientific Research Consultant, <b>Aciont</b><br><br>Philip G. 
      Ralston, Chief Executive Officer, <b>Macuclear</b><br><br>Abraham Scaria, 
      Senior Scientific Director, <b>Genzyme</b><br><br>Timothy Sullivan, 
      Co-Founder, President & Chief Executive Officer, <b>Mystic 
      Pharmaceuticals</b><br><br>Carol B. Toris, Department of Ophthalmology, 
      <b>University of Nebraska Medical Center</b><br><br>Barbara Wirotsko, 
      Chief Medical Officer, <b>Altheos</b><br><br>David Woodward, Investigator, 
      Senior Rsrch Biology, <b>Allergan</b><br><br>Benjamin Yerxa, Chief 
      Scientific Officer, <b>Liquidia Technologies</b><br><br>Kang Zhang, 
      Professor, Ophthalmology and Human Genetics, <b>University of California 
      at San Diego School of Medicine</b>, and <b>VASDHS</b><br><br><b><a 
      href="http://www.gtcbio.com/conference/ocular-diseases-and-drug-discovery-speakers?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">View 
      the speakers webpage</a></b> for the most updated list of 
      speakers.<br> </font></td></tr></tbody></table>
<table cellSpacing=0 cellPadding=0 width=820 align=center>
  <tbody>
  <tr><font size=2 face=Arial>
    <td bgColor=#dceefa height=30>
      <p align=center><b><font size=3 face=arial>CALL FOR 
    PAPERS!</font></b></p></td></font></tr>
  <tr><font size=2 face=Arial>
    <td height=60><font size=2 face=arial><br><b><a 
      href="http://www.gtcbio.com/submit-an-abstract/ocular-diseases-and-drug-discovery?utm_source=newsletter2&utm_medium=ocular&utm_campaign=ocu14I">Submit 
      an abstract</a></b> by </font><b><font size=2 face=arial>February 20, 
      2014</font></b><font size=2 face=arial> and reserve a poster board at the 
      conference to showcase your research. Top 3 abstracts will be selected for 
      an oral presentation. <u><b>Submit your abstract ASAP, space is 
      limited!</b></u><br> </font></td></font></tr>
  <tr>
    <td bgColor=#dceefa height=36>
      <p align=center><b><font face=Arial>SPONSORSHIP OPPORTUNITIES 
      AVAILABLE!</font></b></p></td></tr>
  <tr>
    <td><font size=2 face=Arial><br><b>Contact Amber Kempf (626-256-6405 x110 
      or <a href="mailto:spex@gtcbio.com">spex@gtcbio.com</a>) to learn about 
      GTC's customizable sponsorship and exhibit opportunities. 
      </b><br> </font></td></tr>
  <tr>
    <td bgColor=#dceefa height=40 align=left><b><font size=3 
      face=Arial>Upcoming Conferences</font></b></td></tr>
  <tr>
    <td><font size=2 face=Arial><br><b><a 
      href="http://www.gtcbio.com/conference/cancer-summit-novel-approaches-to-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Cancer 
      Summit: Novel Approaches to Drug Discovery</a></b><br>November 6-8, 2013 
      San Francisco, CA<br><br><b><a 
      href="http://www.gtcbio.com/conference/assay-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">8th 
      Cell Based Assay & Screening Technologies</a></b><br>November 6-8, 
      2013 San Francisco, CA<br><br><b><a 
      href="http://www.gtcbio.com/conference/cancer-epigenetics-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">3rd 
      Cancer Epigenetics</a></b><br>November 6-8, 2013 San Francisco, 
      CA<br><br><b><a 
      href="http://www.gtcbio.com/conference/novel-immunotherapeutics-summit-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Novel 
      Immunotherapeutics Summit 2014</a></b><br>January 29-31, 2014 San Diego, 
      CA<br><font color=#ff3300>20% discount by November 
      29th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/immunoassay%20workshop-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Novel 
      Immunoassays Workshop - Platform & Method for Consistent 
      Results</a></b><br>January 29, 2014 San Diego, CA<br><font 
      color=#ff3300>20% discount by November 29th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/cyto-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">12th 
      Cytokines & Inflammation</a></b><br>January 30-31, 2014 San Diego, 
      CA<br><font color=#ff3300>20% discount by November 
      29th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/immunotherapeutics-and-immunomonitoring-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">6th 
      Immunotherapeutics & Immunomonitoring</a></b><br>January 30-31, 2014 
      San Diego, CA<br><font color=#ff3300>20% discount by November 
      29th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/immunogenicity-and-immunotoxicity-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">2nd 
      Immunogenicity & Immunotoxicity</a></b><br>January 30-31, 2014 San 
      Diego, CA<br><font color=#ff3300>20% discount by November 
      29th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/innate-immunity-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Innate 
      Immunity</a></b><br>January 30-31, 2014 San Diego, CA<br><font 
      color=#ff3300>20% discount by November 29th<br></font><br><b><a 
      href="http://www.gtcbio.com/conference/fb-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Future 
      Biotech Summit</a></b><br>February 20-21, 2014, San Diego, CA<br><font 
      color=#ff3300>20% discount by December 20th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/ubiquitin-research-and-drug-discovery-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">4th 
      Ubiquitin Research and Drug Discovery</a></b><br>February 20-21, 2014, San 
      Diego, CA<br><font color=#ff3300>20% discount by December 
      20th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/orphan-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">2nd 
      Orphan Drugs Research & Commercialization</a></b><br>February 20-21, 
      2014, San Diego, CA<br><font color=#ff3300>20% discount by December 
      20th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/cell-and-gene-therapy-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Cell 
      & Gene Therapy</a></b><br>February 20-21, 2014, San Diego, CA<br><font 
      color=#ff3300>20% discount by December 20th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/tumor-progression-and-therapeutic-resistance-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">4th 
      International Conference on Tumor Progression and Therapeutic 
      Resistance</a></b><br>March 9-11, 2014 Boston, MA<br><font 
      color=#ff3300>20% discount by January 9th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/biomarker-summit-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Biomarker 
      Summit 2014</a></b><br>March 19-21, 2014 San Diego, CA<br><font 
      color=#ff3300>20% discount by January 19th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/oncology-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">7th 
      Oncology Biomarkers</a><br></b>March 19-21, 2014 San Diego, CA<br><font 
      color=#ff3300>20% discount by January 19th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/neurological-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">3rd 
      Neurological Biomarkers</a></b><br>March 19-21, 2014 San Diego, 
      CA<br><font color=#ff3300>20% discount by January 19th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/inflammatory-and-immunological-biomarkers-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">3rd 
      Inflammatory & Immunological Biomarkers</a></b><br>March 19-21, 2014 
      San Diego, CA<br><font color=#ff3300>20% discount by January 
      19th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/diabetes-summit-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Diabetes 
      Summit 2014</a></b><br>April 23-25, 2014 Cambridge, MA<br><font 
      color=#ff3300>20% discount by February 23rd </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/diabetes-drug-discovery-and-development-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">7th 
      Diabetes Drug Discovery & Development</a></b><br>April 23-25, 2014 
      Cambridge, MA<br><font color=#ff3300>20% discount by February 23rd 
      </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/diabetes-partnering-and-deal-making-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">4th 
      Diabetes Partnering and Deal-Making</a></b><br>April 23-25, 2014 
      Cambridge, MA<br><font color=#ff3300>20% discount by February 23rd 
      </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/stem-cell-summit-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Stem 
      Cell Summit 2014</a></b><br>April 23-25, 2014 Cambridge, MA<br><font 
      color=#ff3300>20% discount by February 23rd </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/stem-cell-research-and-regenerative-medicine-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Stem 
      Cell Research & Regenerative Medicine</a></b><br>April 23-25, 2014 
      Cambridge, MA<br><font color=#ff3300>20% discount by February 23rd 
      </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/stem-cell-commercialization-and-partnering-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Stem 
      Cell Commercialization & Partnering</a></b><br>April 23-25, 2014 
      Cambridge, MA<br><font color=#ff3300>20% discount by February 23rd 
      </font><br><br><b><a 
      href="http://www.gtcbio.com/conference/protein-kinases-drug-discovery-europe-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Protein 
      Kinases in Drug Discovery - Europe</a></b><br>May 8-9, 2014 Berlin, 
      Germany<br><font color=#ff3300>20% discount by March 
      8th</font><br><br><b><a 
      href="http://www.gtcbio.com/conference/medchem-overview?utm_source=newsletter2&utm_medium=ocular&utm_content=conflist&utm_campaign=ocu14I">Drug 
      Design & Medicinal Chemistry - Europe</a></b><br>May 8-9, 2014 Berlin, 
      Germany<br><font color=#ff3300>20% discount by March 
      8th</font><br> </font></td></tr>
  <tr>
    <td><font style="FONT-SIZE: 8pt" color=#c0c0c0 face=Arial>This 
      advertisement is sent to support@bioontology.org from GTC, 635 W. Foothill Blvd, 
      Monrovia, CA 91016. If you prefer not to receive further messages from 
      this sender, please forward this email to <a 
      href="mailto:remove@gtcbio.com"><font 
      color=#c0c0c0>remove@gtcbio.com</font></a> or use the following link to 
      unsubscribe <a 
      href="http://gtcbio.com/unsubscribe.php?emailid=support@bioontology.org"><font 
      color=#c0c0c0>http://gtcbio.com/unsubscribe.php?emailid=support@bioontology.org</font></a></font></td></tr></tbody></table></body></html>